Cytosorbents (CTSO) Accumulated Expenses (2010 - 2026)
Cytosorbents' (CTSO) quarterly Accumulated Expenses came in at $6.0 million in Q1 2026, little changed YoY from $5.9 million in Q1 2025, and down 5.38% on a QoQ basis from $6.3 million in Q4 2025.
Cytosorbents (CTSO) Accumulated Expenses (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Accumulated Expenses data on file, last reported at $6.0 million in Q1 2026.
- Quarterly Accumulated Expenses changed 0.39% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (changed 0.39% YoY) and the FY2025 annual result came in at $6.3 million, up 4.43% from the prior year.
- Accumulated Expenses retreated to $6.0 million in Q1 2026, from $6.3 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $9.4 million in Q1 2022 to a low of $5.5 million in Q3 2024.
- A 5-year average of $6.9 million and a median of $6.6 million in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses climbed 22.84% — and 2023, when it plunged 32.18%.
- Tracing CTSO's Accumulated Expenses over 5 years: stood at $8.0 million in 2022, then dropped by 7.43% to $7.4 million in 2023, then decreased by 18.04% to $6.0 million in 2024, then climbed by 4.43% to $6.3 million in 2025, then dropped by 5.38% to $6.0 million in 2026.
- The last three Accumulated Expenses figures came in at $6.0 million (Q1 2026), $6.3 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Cytosorbents | 23.26 Mn | 18.85 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.28 Mn |
| Mar 31, 2026 | 5.96 Mn |
| Dec 31, 2025 | 6.30 Mn |
| Sep 30, 2025 | 6.56 Mn |
| Jun 30, 2025 | 5.95 Mn |
| Mar 31, 2025 | 5.94 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | 7.43 Mn |
| Dec 31, 2023 | 7.36 Mn |
| Sep 30, 2023 | 7.28 Mn |
| Jun 30, 2023 | 7.03 Mn |
| Mar 31, 2023 | 6.35 Mn |
| Dec 31, 2022 | 7.95 Mn |
| Sep 30, 2022 | 7.39 Mn |
| Jun 30, 2022 | 8.01 Mn |
| Mar 31, 2022 | 9.36 Mn |
| Dec 31, 2021 | 10.31 Mn |
| Sep 30, 2021 | 7.45 Mn |